Log on / register
Feedback | Support | My details
Pathways for aberrant angiogenesis in pancreatic cancer.
Korc M
Mol Cancer 2003 Jan 7, 2:8
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Harnessing preclinical mouse models to inform human clinical cancer trials.
Gutmann DH, Hunter-Schaedle K, Shannon KM
J Clin Invest 2006 Apr, 116:847-52
 [PubMed Central] [PubMed] [Related articles]
2.
The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.
Tassi E, Wellstein A
Semin Oncol 2006 Dec, 33(6 Suppl 11):S50-6
 [PubMed Central] [PubMed] [Related articles]
3.
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer.
Cho K, Ishiwata T, Uchida E, Nakazawa N, Korc M, Naito Z, Tajiri T
Am J Pathol 2007 Jun, 170:1964-74
 [PubMed Central] [PubMed] [Related articles]
4.
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.
Aikawa T, Whipple CA, Lopez ME, Gunn J, Young A, Lander AD, Korc M
J Clin Invest 2008 Jan, 118:89-99
 [PubMed Central] [PubMed] [Related articles]
5.
Endostatin expression in a pancreatic cell line is modulated by a TNFalpha-dependent elastase.
Brammer RD, Bramhall SR, Eggo MC
Br J Cancer 2005 Oct 31, 93:1024-8
 [PubMed Central] [PubMed] [Related articles]
6.
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S
Cancer Res 2008 Aug 1, 68:6100-8
 [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.